ASSESSMENT OF THE RISK OF IRON MALABSORPTION OCCURRING IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES) TREATED WITH LONG-TERM GASTRIC ANTISECRETORY THERAPY
Ca. Stewart et al., ASSESSMENT OF THE RISK OF IRON MALABSORPTION OCCURRING IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES) TREATED WITH LONG-TERM GASTRIC ANTISECRETORY THERAPY, Gastroenterology, 110(4), 1996, pp. 264-264